Advertisement

ADVERTISEMENT

Jolynn Tumolo

Brain health
News
Environmental Pollutants Linked With Increased ALS Risk, Mortality
11/21/2023
Jolynn Tumolo
An environmental risk score was associated with amyotrophic lateral sclerosis (ALS) risk and mortality in a Michigan cohort.
An environmental risk score was associated with amyotrophic lateral sclerosis (ALS) risk and mortality in a Michigan cohort.
An environmental risk score was...
11/21/2023
Neurology
News
Drug Purchases From Foreign Countries Lack US Safeguards
11/21/2023
Jolynn Tumolo
Pharmacists, prescribers, and other team members involved in prescription drug delivery can help patients by talking to them about drug safety “and the dangers of purchasing unregulated drugs through illegal online pharmacies,” the authors...
Pharmacists, prescribers, and other team members involved in prescription drug delivery can help patients by talking to them about drug safety “and the dangers of purchasing unregulated drugs through illegal online pharmacies,” the authors...
Pharmacists, prescribers, and...
11/21/2023
Pharmacy Learning Network
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
News
Gene Therapy Improves Motor Function but Misses Primary Endpoint in Duchenne Muscular Dystrophy Trial
11/21/2023
Jolynn Tumolo
The single-dose gene therapy Elevidys (delandistrogene moxeparvovec-rokl) increased motor function in children ages 4 through 7 years with Duchenne muscular dystrophy compared with placebo.
The single-dose gene therapy Elevidys (delandistrogene moxeparvovec-rokl) increased motor function in children ages 4 through 7 years with Duchenne muscular dystrophy compared with placebo.
The single-dose gene therapy...
11/21/2023
Neurology
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
News
Intranasal Fasedienol Safe, Well-Tolerated in Adults With Social Anxiety Disorder
11/20/2023
Jolynn Tumolo
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol was safe and well tolerated, and improved overall symptom control, in adults with social anxiety disorder (SAD), according to a poster presented at NEI Congress in Colorado Springs, Colorado, earlier this month.
Repeated, as-needed fasedienol...
11/20/2023
Psych Congress Network
Add-on N-acetyl-cysteine, Polyunsaturated Fatty Acids May Benefit Patients With Schizophrenia
News
Add-on N-acetyl-cysteine, Polyunsaturated Fatty Acids May Benefit Patients With Schizophrenia
11/20/2023
Jolynn Tumolo
Adjunctive N-acetyl-cysteine and polyunsaturated fatty acids can be provisionally recommended for improving negative symptoms, general psychopathology, and possibly cognition in patients with schizophrenia, according to a systematic umbrella...
Adjunctive N-acetyl-cysteine and polyunsaturated fatty acids can be provisionally recommended for improving negative symptoms, general psychopathology, and possibly cognition in patients with schizophrenia, according to a systematic umbrella...
Adjunctive N-acetyl-cysteine and...
11/20/2023
Psych Congress Network
Improving Deep Sleep in Older Adults May Lower Dementia Risk
News
Improving Deep Sleep in Older Adults May Lower Dementia Risk
11/20/2023
Jolynn Tumolo
Each percentage decrease in slow-wave sleep per year in people 60 years and older is associated with a 27% increased risk of dementia, according to study results published in JAMA Neurology. “Slow-wave sleep, or deep sleep, supports the...
Each percentage decrease in slow-wave sleep per year in people 60 years and older is associated with a 27% increased risk of dementia, according to study results published in JAMA Neurology. “Slow-wave sleep, or deep sleep, supports the...
Each percentage decrease in...
11/20/2023
Neurology
News
Pain Injection Recalled
11/16/2023
Jolynn Tumolo
The FDA is recalling a partial opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.
The FDA is recalling a partial opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.
The FDA is recalling a partial...
11/16/2023
Pharmacy Learning Network
News
Potential for Glass Particulate in Injections Prompts Recall
11/16/2023
Jolynn Tumolo
A Class I recall has been issued for 24,900 vials of 4.2% sodium bicarbonate injection distributed by Hospira, a Pfizer company, because of the potential presence of glass particulate, according to the November 15, 2023, US Food and Drug...
A Class I recall has been issued for 24,900 vials of 4.2% sodium bicarbonate injection distributed by Hospira, a Pfizer company, because of the potential presence of glass particulate, according to the November 15, 2023, US Food and Drug...
A Class I recall has been issued...
11/16/2023
Pharmacy Learning Network
bipolar disorder graphic
News
Metformin Helps Prevent Weight Gain in Youth Taking Medication for Bipolar Disorder
11/15/2023
Jolynn Tumolo
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug...
11/15/2023
Psych Congress Network
News
Antiarrhythmic Injection Under Class I Recall
11/15/2023
Jolynn Tumolo
More than 20,000 vials of 1% lidocaine hydrochloride injection distributed by Hospira are under a Class I recall because they may contain glass particulate, according to the November 15, 2023, US Food and Drug Administration (FDA) Enforcement...
More than 20,000 vials of 1% lidocaine hydrochloride injection distributed by Hospira are under a Class I recall because they may contain glass particulate, according to the November 15, 2023, US Food and Drug Administration (FDA) Enforcement...
More than 20,000 vials of 1%...
11/15/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use